Recent advancements in neuroimaging technology have opened a new frontier in understanding the effects of psychedelic compounds on the human brain. Among these, psilocybin, the primary psychoactive component in psilocybin-containing fungi (often called “psychedelic mushrooms”), has become a significant subject of scientific inquiry. Researchers are increasingly using controlled, clinical studies to investigate how this compound modulates brain function, communication, and structure. This research aims to move beyond historical and anecdotal accounts to build a rigorous, evidence-based understanding of psilocybin’s neural mechanisms from a neuroscience perspective.
This article provides a purely informational overview of the current state of scientific research on how psychedelic mushrooms affect the brain. The content presented here is based on findings from peer-reviewed studies, primarily involving brain imaging techniques like functional magnetic resonance imaging (fMRI) and positron emission tomography (PET). It is essential to understand that this article does not provide any form of medical advice, guidance, or experiential descriptions. The focus is exclusively on what scientific observation in controlled research settings has revealed about the brain’s response to psilocybin.
What Happens in the Brain When Psychedelic Mushrooms Are Studied
When psilocybin is ingested, the body rapidly metabolizes it into its active form, psilocin. This compound bears a structural similarity to serotonin, a key neurotransmitter that regulates mood, cognition, and perception. Psilocin’s primary mechanism of action is its interaction with serotonin receptors in the brain, particularly the serotonin 2A (5-HT2A) receptor. Studies using PET imaging have shown that psilocin binds to these receptors with high affinity, with one study from 2022 noting between 63% and 74% receptor occupancy in key cortical areas after a clinical dose of psilocybin (source).
This potent agonism at the 5-HT2A receptor is believed to be the primary driver of the subsequent changes in brain activity observed in research settings. It is this interaction that triggers a cascade of downstream effects on neural signaling, functional connectivity, and network dynamics. These changes are temporary and are observed under controlled laboratory conditions, providing a window into the complex interplay between neurochemistry and consciousness. It is important to note that while the 5-HT2A receptor is the main target, psilocin also interacts with other serotonin receptor subtypes, though the significance of these interactions is still an area of active investigation.
Psychedelic Mushrooms and Brain Function
Neuroscience research has observed that psilocybin temporarily alters patterns of communication between different brain regions. The brain operates as a complex network where distinct areas communicate with each other to perform various functions. This communication, known as functional connectivity, can be measured using fMRI, which tracks changes in blood flow and oxygenation. Studies have shown that under the influence of psilocybin, the brain’s established patterns of functional connectivity are significantly disrupted.
A highly cited 2012 study from Imperial College London, led by Dr. Robin Carhart-Harris, used fMRI to observe brain activity after administering psilocybin intravenously. The researchers reported a surprising decrease in cerebral blood flow and BOLD (blood-oxygen-level-dependent) signal in key connector hubs of the brain, such as the thalamus and the anterior and posterior cingulate cortices (source). This finding ran counter to the prevailing assumption that psychedelic effects were caused by increased brain activity. The study suggested that the profound changes in consciousness were instead linked to a temporary state of less constrained and more disorganized brain activity, allowing for novel patterns of communication between regions that do not typically interact.
These observed changes are temporary and dose-dependent, lasting for the duration of the drug’s acute effects. Current research does not support claims of permanent alterations to these fundamental communication patterns from a single administration in a controlled setting. The findings suggest a transient “desynchronization” of the brain’s normal operating mode, rather than a lasting change in its functional architecture. [Internal link: Brain Regions Glossary]
The Default Mode Network (DMN) and Psychedelic Mushrooms
Much of the neuroscientific discussion around psychedelic mushrooms centers on their effect on the Default Mode Network (DMN). The DMN is a large-scale brain network consisting of several interconnected hubs, including the medial prefrontal cortex (mPFC) and the posterior cingulate cortex (PCC). This network is most active when the brain is at rest and not focused on a specific external task. It is primarily associated with internal processes such as self-referential thought, autobiographical memory, and constructing our internal narrative or sense of self.
Neuroimaging studies have consistently shown that psilocybin significantly decreases activity and functional connectivity within the DMN. The aforementioned 2012 fMRI study by Carhart-Harris and his team at Imperial College London was among the first to demonstrate this, finding that psilocybin caused a significant “decoupling” between the mPFC and the PCC (source). A 2022 systematic review published in the International Journal of Neuropsychopharmacology confirmed this pattern, concluding that across major classical psychedelics, there is a consistent acute disruption of connectivity within the DMN (source). This temporary disintegration of the DMN is thought to correlate with the subjective experience of “ego dissolution” or a diminished sense of self often reported in psychedelic research participants.
By reducing the integrity of this highly centralized network, psilocybin appears to allow for a more flexible and less constrained state of brain function, where global connectivity between different brain networks increases. This observed effect on the DMN is one of the most robust findings in psychedelic neuroscience to date, providing a compelling neural correlate for the profound shifts in consciousness reported in clinical studies. [Internal link: Serotonin & 5-HT2A Explained]
Psychedelic Mushrooms and Neuroplasticity
Neuroplasticity refers to the brain’s ability to reorganize itself by forming new neural connections or adjusting existing ones. This is a fundamental property of the brain that underlies learning and memory. Research into psychedelic mushrooms and neuroplasticity is an emerging and complex field, and it is crucial to define its terms precisely. This research distinguishes between different types of plasticity, including synaptic plasticity (changes in the strength of connections between neurons), structural changes (like the growth of new dendritic spines), and neurogenesis (the birth of new neurons, which is rare in the adult human brain and often misunderstood in popular science).
Most of the current evidence for psilocybin-induced neuroplasticity comes from preclinical animal studies. For example, a 2021 study published in the International Journal of Molecular Sciences administered psilocybin to pigs and observed a significant increase in synaptic density in the hippocampus and prefrontal cortex that persisted for seven days (source). Other studies in mice have shown that psilocybin can promote the growth of dendritic spines, the small protrusions on neurons that receive signals from other neurons. These findings suggest a potential biological mechanism for facilitating structural and functional changes in the brain.
However, it is critical to state that this research is still in its early stages, and what is observed in animal models may not directly translate to humans. While the findings are suggestive of a potential for psilocybin to promote neural plasticity, much more research is needed to determine if and how these effects occur in the human brain and what their functional significance might be. Claims of large-scale neurogenesis or permanent structural changes in humans are not supported by current evidence.
Do Psychedelic Mushrooms “Rewire” the Brain?
The term “rewiring” is often used in media headlines and popular discussions to describe the effects of psychedelics on the brain. While this phrase is a compelling metaphor, it is not a scientifically accurate conclusion. It oversimplifies the complex and nuanced findings from neuroscience research. The brain is not a set of hardwired circuits that can be simply re-routed. Instead, it is a dynamic and adaptive system that is constantly adjusting its connections.
The evidence from animal studies points towards psilocybin’s potential to promote synaptic plasticity, which could be described as a subtle and activity-dependent form of rewiring at a microscopic level. However, this is a far cry from the idea of a large-scale, permanent overhaul of the brain’s entire network architecture. The observed effects in human fMRI studies, such as the temporary disintegration of the DMN and increased global connectivity, are transient functional changes, not permanent structural ones. Scientific caution is necessary to avoid overstating the implications of these preliminary findings. The metaphor of “rewiring” can create unrealistic expectations and misinterpret the current state of knowledge.
Limitations of Current Research
While the field of psychedelic neuroscience is advancing rapidly, it is important to acknowledge the limitations of the current body of research. Many of the foundational human studies have been conducted with small sample sizes, which can limit the generalizability of the findings. Furthermore, these studies are conducted in highly controlled, clinical environments with carefully screened participants, which may not reflect real-world conditions.
Most studies also have short follow-up periods, meaning the long-term effects of psilocybin on brain function and structure are not yet well understood. There is a lack of longitudinal data tracking changes over months or years. Finally, a significant portion of the research on neuroplasticity has been conducted in animal models, and the extent to which these findings apply to humans remains an open question. These limitations underscore the need for continued, rigorous investigation before definitive conclusions can be drawn.
Current Areas of Ongoing Research
Research into psilocybin’s effects on the brain is a vibrant and expanding field. Current investigations continue to use advanced brain-imaging techniques to map the acute and lasting effects of psilocybin with greater precision. Neurobiologists are conducting receptor-level research to better understand the complex pharmacology of psilocybin and its interactions with various serotonin receptors. Additionally, a significant amount of research is focused on the potential mental health applications of psilocybin-assisted therapy, although this article maintains a non-clinical, neuroscience-focused perspective. [Internal link: Contraindications & Interactions Hub]
Conclusion
Scientific research has begun to illuminate the intricate ways in which psychedelic mushrooms affect the brain. The established evidence points to psilocybin’s primary action at the 5-HT2A receptor, leading to temporary but profound changes in brain network dynamics, most notably the disruption of the Default Mode Network. This allows for a state of increased communication between different brain regions. Emerging preclinical evidence from animal studies suggests a potential for psilocybin to promote neuroplasticity by increasing synaptic density, but this is not yet well-established in humans.
What remains under investigation are the long-term effects of these changes and their precise relationship to the subjective and potential therapeutic effects observed in clinical trials. The neuroscience of psychedelics is an evolving field, and it is essential to interpret the findings with care and responsibility, avoiding sensationalism and adhering to the evidence. As research continues, a clearer picture of how these compounds work in the brain will undoubtedly emerge. [Internal link: Psychedelic Mushrooms: A Science-First Overview]
Sources & Further Reading
1.Barrett, F. S., et al. (2022). Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin. Neuropsychopharmacology. (source)
2.Carhart-Harris, R. L., et al. (2012). Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proceedings of the National Academy of Sciences, 109(6), 2138-2143. (source)
3.Gattuso, J. J., et al. (2023). Default Mode Network Modulation by Psychedelics: A Systematic Review. International Journal of Neuropsychopharmacology, 26(3), 155-188. (source)
4.Raval, N. R., et al. (2021). A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain. International Journal of Molecular Sciences, 22(2), 835. (source)
5.Imperial College London, Centre for Psychedelic Research
6.Johns Hopkins Center for Psychedelic & Consciousness Research
Educational Disclaimer
This article is for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The information provided does not constitute medical, psychological, or legal advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Readers should consult qualified professionals for any personal decisions related to their health or well-being.